Shu-Chen Lu

862 total citations · 1 hit paper
13 papers, 697 citations indexed

About

Shu-Chen Lu is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Shu-Chen Lu has authored 13 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Surgery. Recurrent topics in Shu-Chen Lu's work include Diabetes Treatment and Management (5 papers), Receptor Mechanisms and Signaling (4 papers) and Neuropeptides and Animal Physiology (2 papers). Shu-Chen Lu is often cited by papers focused on Diabetes Treatment and Management (5 papers), Receptor Mechanisms and Signaling (4 papers) and Neuropeptides and Animal Physiology (2 papers). Shu-Chen Lu collaborates with scholars based in United States, Japan and China. Shu-Chen Lu's co-authors include Murielle M. Véniant, Todd Hager, Shanaka Stanislaus, Richard Lindberg, Narumol Chinookoswong, Melissa Graham, Randy Hecht, Yvonne Lau, Yang Li and Jing Xu and has published in prestigious journals such as PLoS ONE, Endocrine Reviews and Journal of Lipid Research.

In The Last Decade

Shu-Chen Lu

12 papers receiving 681 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings

2024 115 citations Murielle M. Véniant, Shu-Chen Lu et al. Nature Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shu-Chen Lu United States	9	413	238	143	122	98	13	697
Rodolphe Dusaulcy Switzerland	12	384 0.9×	106 0.4×	177 1.2×	164 1.3×	49 0.5×	20	658
Ingo Uphues Germany	10	404 1.0×	174 0.7×	170 1.2×	206 1.7×	35 0.4×	17	617
Susanna Mac United States	6	252 0.6×	406 1.7×	74 0.5×	194 1.6×	48 0.5×	9	569
Rupert G. Yip United States	6	247 0.6×	464 1.9×	125 0.9×	224 1.8×	83 0.8×	6	645
Victoria E R Parker United Kingdom	5	199 0.5×	301 1.3×	88 0.6×	167 1.4×	35 0.4×	8	441
Yoichi Hamada Japan	11	175 0.4×	273 1.1×	175 1.2×	143 1.2×	79 0.8×	19	668
Andrea Bell United States	10	254 0.6×	320 1.3×	149 1.0×	42 0.3×	61 0.6×	14	697
Luca Meoli Germany	10	229 0.6×	224 0.9×	267 1.9×	277 2.3×	49 0.5×	10	756
Prasad G. Kamble Sweden	13	104 0.3×	127 0.5×	163 1.1×	124 1.0×	43 0.4×	21	410
Laurent Pascual-Le Tallec France	7	318 0.8×	478 2.0×	95 0.7×	152 1.2×	32 0.3×	8	752

Countries citing papers authored by Shu-Chen Lu

Since Specialization

Citations

This map shows the geographic impact of Shu-Chen Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu-Chen Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu-Chen Lu more than expected).

Fields of papers citing papers by Shu-Chen Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu-Chen Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu-Chen Lu. The network helps show where Shu-Chen Lu may publish in the future.

Co-authorship network of co-authors of Shu-Chen Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Shu-Chen Lu. A scholar is included among the top collaborators of Shu-Chen Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu-Chen Lu. Shu-Chen Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Liu, Clarissa M., Elizabeth A. Killion, Rola Hammoud, et al.. (2025). GIPR-Ab/GLP-1 peptide–antibody conjugate requires brain GIPR and GLP-1R for additive weight loss in obese mice. Nature Metabolism. 7(6). 1266–1281. 11 indexed citations

Lu, Shu-Chen, et al.. (2025). Prediction of disability levels and research on nursing economic costs for elderly people in China. PLoS ONE. 20(11). e0336605–e0336605.

Véniant, Murielle M., Shu-Chen Lu, Larissa Atangan, et al.. (2024). A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings. Nature Metabolism. 6(2). 290–303. 115 indexed citations breakdown →

Lu, Shu-Chen, Michelle Chen, Larissa Atangan, et al.. (2021). GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys. Cell Reports Medicine. 2(5). 100263–100263. 71 indexed citations

Killion, Elizabeth A., Shu-Chen Lu, Madeline Fort, et al.. (2019). Glucose-Dependent Insulinotropic Polypeptide Receptor Therapies for the Treatment of Obesity, Do Agonists = Antagonists?. Endocrine Reviews. 41(1). 1–21. 72 indexed citations

Killion, Elizabeth A., Shu-Chen Lu, Madeline Fort, et al.. (2019). Glucose-Dependent Insulinotropic Polypeptide Receptor Therapies For The Treatment Of Obesity, Do Agonists = Antagonists?. Endocrine Reviews. 3 indexed citations

He, Zhanlong, et al.. (2015). Relevance and Clinical Significance of Serum Resistin Level in Obese T2DM Rhesus Monkey Models. Experimental and Clinical Endocrinology & Diabetes. 123(8). 508–513. 6 indexed citations

Lu, Shu-Chen, Larissa Atangan, Ki Won Kim, et al.. (2012). An apoA-I mimetic peptibody generates HDL-like particles and increases alpha-1 HDL subfraction in mice. Journal of Lipid Research. 53(4). 643–652. 16 indexed citations

Lin, Tung‐Liang, Ming‐Chung Kuo, Lee‐Yung Shih, et al.. (2012). Value of surveillance computed tomography in the follow-up of diffuse large B-cell and follicular lymphomas. Annals of Hematology. 91(11). 1741–1745. 28 indexed citations

10.

Graham, Melissa, Larissa Atangan, Shu-Chen Lu, et al.. (2010). Strategy for the Identification of GPR23/LPA ₄ Receptor Agonists and Inverse Agonists. Assay and Drug Development Technologies. 8(4). 459–470. 5 indexed citations

11.

Liu, Xuesong, Xudong Zhao, Lingling Wang, et al.. (2010). Germinal Cell Aplasia in Kif18a Mutant Male Mice Due to Impaired Chromosome Congression and Dysregulated BubR1 and CENP-E. Genes & Cancer. 1(1). 26–39. 35 indexed citations

12.

Lu, Shu-Chen, Jing Xu, Narumol Chinookoswong, et al.. (2009). An Acyl-Ghrelin-Specific Neutralizing Antibody Inhibits the Acute Ghrelin-Mediated Orexigenic Effects in Mice. Molecular Pharmacology. 75(4). 901–907. 46 indexed citations

13.

Xu, Jing, Shanaka Stanislaus, Narumol Chinookoswong, et al.. (2009). Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models—association with liver and adipose tissue effects. American Journal of Physiology-Endocrinology and Metabolism. 297(5). E1105–E1114. 289 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact